Skip to Content

GPI S1 (Docusate Sodium 100 mg)

Pill with imprint GPI S1 is White, Round and has been identified as Docusate Sodium 100 mg. It is supplied by Gemini Pharmaceuticals, Inc..

Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GPI S1

Docusate Sodium

Imprint
GPI S1
Strength
100 mg
Color
White
Shape
Round
Availability
Rx and/or OTC
Drug Class
Laxatives
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gemini Pharmaceuticals, Inc.
National Drug Code (NDC)
51645-0750

Get help with Imprint Code FAQs.

Related Images for "GPI S1"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.